The All-Russian Research Institute of Animal Protection (VNIIZH) has developed a vaccine for the prevention of infectious bursal disease (Gumboro disease). The drug was named VNIIZH IBD-Medius, according to the press service of the Rosselkhoznadzor, which manages the Institute.
The drug contains an attenuated strain of the Gumboro disease virus. It develops a strong immunity, and it is capable of overcoming high transovarial immunity in chicks, and does not have a negative impact on the immune system, including the bursa — an organ responsible for immune development in young animals, said the press service, noting that currently, there are no vaccines on the domestic market based on this strain.
On October 7th, the vaccine received government registration and is now available to general consumers, the Rosselkhoznadzor says.
Gumboro disease, or infectious bursal disease, is a highly contagious viral disease in young chickens (2-15 weeks) that attacks the bursa, leading to immune suppression and increased vulnerability to other infections. The disease is controlled primarily through vaccination.
The production of veterinary drugs in Russia is entering a new stage, as the market is growing and the segment of domestic medicines is actively developing, says Timur Chibilyaev, Executive Director of the National Veterinary Association. He told GxP News how veterinary drug manufacturing is moving from import substitution to technological leadership, with a focus on developing more innovative and effective domestic medicines.
